Meal timing tested for new drug TS-172 in healthy volunteers
NCT ID NCT07084961
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tested a drug called TS-172 in 16 healthy Japanese men to see if taking it before or after a meal changes how the body handles phosphorus and sodium. The trial is complete and focused on safety and basic effects, not on treating any disease. It provides initial data on how the drug works in the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TS-172
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Taisho Pharmaceutical Co., Ltd selected site
Tokyo, Japan